Yayınlarımız

Atay, L. Ö., Saka, E., Akdemir, Ü. Ö., Yetim Arsava, E., Balcı, E., Arsava, E. M.,  ... Topçuoğlu, M. A.(2023). Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.  Current Alzheimer research , vol.20, no.7, 481-495.                

Saka, E., ATAY, L. Ö., AKDEMİR, Ü. Ö., Yetim, E., BALCI, E., ARSAVA, E. M.,  ... TOPÇUOĞLU, M. A.(2023). Cerebral vasomotor reactivity across the continuum of subjective cognitive impairment, amnestic mild cognitive impairment and probable Alzheimer's dementia: A transcranial Doppler and PET/MRI study.  JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM , vol.43, no.1, 129-137.                

Saka Topçuoğlu, E., AKDEMİR, Ü. Ö.,  & ATAY, L. Ö., (2022). What is New in Nuclear Medicine Imaging for Dementia.  Noropsikiyatri Arsivi , vol.59.                

Akdemir, Ü. Ö., Çapraz, İ., Gülbahar Ateş, S., Şeker, K., Aydos, U., Kurt, G.,  ... Karabacak, N.(2020). Evaluation of brain FDG PET images in temporal lobe epilepsy for lateralization of epileptogenic focus using data mining methods.  TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.4, 738-748.    

Akdemir, Ü. Ö., Bora, H. A.,  & Atay, L. Ö., (2021). Dopamine transporter SPECT imaging in Parkinson's disease and parkinsonian disorders.  TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.2, 400-410.        

Balcı, E., Akdemir, Ü. Ö., Saka, E.,  & Atay, L. Ö., (2023).  ALZHEİMER HASTALIĞININ AMİLOİD PET İLE TANISINDA SAYISAL YAKLAŞIM: GÜFAPET . 2023 Ulusal Nöroloji Kongresi (pp.42).                 

Balcı, E., Akdemir, Ü. Ö., Topçuoğlu, M. A., Saka, E.,  & Atay, L. Ö., (2023).  Cluster Analysis in Binary Classification of Amyloid PET/MR Imaging with/without-Partial Volume Effect Correction . Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria                

Atay, L. Ö., Akdemir, Ü. Ö., Yetim Arsava, E., Balcı, E., Arsava, E. M., Topçuoğlu, M. A.,  ... Saka Topçuoğlu, E.(2021).  Multimodal brain imaging demonstrates that both amyloid burden and glucose metabolism predict the severity of cognitive impairment in patients with Alzheimer's disease . Alzheimer’s Association International Conference 2021, Colorado, United States Of America